Licensable university IP
Lipoxin and lipoxin analogue mediated neuroprotection and treatments
Lipoxin and lipoxin analogue mediated neuroprotection and treatments is marketed for licensing by University of California. It is documented in US patent US 11,439,615. The current assignee of record is University Health Network. Google Patents reports its legal status as “Active” (an automated indicator, not a legal determination). Its expected expiration is 2038-11-09. Note: the patent's assignee of record is University Health Network, not University of California; confirm that University of California can license it before relying on this listing.
The patent's current assignee of record is University Health Network, which differs from the marketing institution (University of California). Confirm licensing rights with the assignee of record before relying on this listing.
Patent picture
| Field | Value | Reliability | Source |
|---|---|---|---|
| US patent | US 11,439,615 | High | Google Patents |
| Patent title | Lipoxin and lipoxin analogue mediated neuroprotection and treatments | High | Google Patents |
| Current assignee | University Health Network | Good | Google Patents |
| Original assignee | University Health Network | Good | Google Patents |
| Legal status | Active | Moderate | Google Patents |
| Filing date | 2018-03-09 | High | Google Patents |
| Priority date | 2017-03-09 | High | Google Patents |
| Publication date | 2022-09-13 | High | Google Patents |
| Expected expiration | 2038-11-09 | Moderate | Google Patents |
- High 90% and up
- Good 80 to 89%
- Moderate 70 to 79%
Legal status is Google Patents' automated indicator, not a legal determination.
Joined to US 11,439,615 by its printed patent number (a deterministic match), then enriched from public Google Patents data. Fields are shown only where resolved against a public source; unresolved fields are omitted, never guessed.
Original listing
This technology is marketed for licensing by University of California. View the original listing.